Recombinant human immunodeficiency virus-1 transactivator of transcription1-86 allosterically modulates dopamine transporter activity.
作者信息
Zhu Jun, Ananthan Subramaniam, Mactutus Charles F, Booze Rosemarie M
机构信息
Department of Pharmaceutical and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.
出版信息
Synapse. 2011 Nov;65(11):1251-4. doi: 10.1002/syn.20949. Epub 2011 May 17.
Abstract
摘要
相似文献
1
Recombinant human immunodeficiency virus-1 transactivator of transcription1-86 allosterically modulates dopamine transporter activity.重组人免疫缺陷病毒1型转录激活因子1-86对多巴胺转运体活性具有变构调节作用。
Synapse. 2011 Nov;65(11):1251-4. doi: 10.1002/syn.20949. Epub 2011 May 17.
2
HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.HIV-1转基因大鼠前额叶皮质和纹状体中[³H]多巴胺摄取增加。
J Neurovirol. 2016 Jun;22(3):282-92. doi: 10.1007/s13365-015-0391-6. Epub 2015 Oct 26.
3
Identification of pyrimidine structure-based compounds as allosteric ligands of the dopamine transporter as therapeutic agents for NeuroHIV.鉴定基于嘧啶结构的化合物作为多巴胺转运体的变构配体作为神经艾滋病的治疗药物。
J Pharmacol Exp Ther. 2025 Feb;392(2):100021. doi: 10.1124/jpet.124.002138. Epub 2024 Nov 22.
4
Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter.SRI-20041 和 SRI-30827 对可卡因和 HIV-1 Tat 蛋白与人多巴胺转运体结合的变构调节作用。
Sci Rep. 2017 Jun 16;7(1):3694. doi: 10.1038/s41598-017-03771-0.
5
HIV-1 protein Tat inhibits vesicular monoamine transporter-2 activity in rat striatum.HIV-1蛋白Tat抑制大鼠纹状体中的囊泡单胺转运体2活性。
Synapse. 2012 Aug;66(8):755-7. doi: 10.1002/syn.21564. Epub 2012 May 23.
6
Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice.新型别构调节剂 Southern Research Institute-32743 逆转诱导型转录激活子转基因小鼠尾壳核中 HIV-1 转录激活因子诱导的多巴胺释放增加。
J Pharmacol Exp Ther. 2023 Feb;384(2):306-314. doi: 10.1124/jpet.122.001291. Epub 2022 Dec 1.
7
Effects of SRI-32743, a Novel Quinazoline Structure-Based Compound, on HIV-1 Tat and Cocaine Interaction with Norepinephrine Transporter.新型喹唑啉结构化合物 SRI-32743 对 HIV-1 Tat 与去甲肾上腺素转运体相互作用及可卡因的影响。
Int J Mol Sci. 2024 Jul 18;25(14):7881. doi: 10.3390/ijms25147881.
8
[H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription Protein.在表达 HIV-1 转录激活蛋白的转基因小鼠的前额叶皮层中，多巴胺和去甲肾上腺素转运体的多巴胺摄取减少。
J Pharmacol Exp Ther. 2020 Aug;374(2):241-251. doi: 10.1124/jpet.120.266023. Epub 2020 May 27.
9
SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice.SRI-32743，一种新型的变构调节剂，可减弱 HIV-1 Tat 蛋白诱导的多巴胺转运体抑制，并减轻 HIV-1 Tat 转基因小鼠中海洛因奖赏的增强作用。
Neuropharmacology. 2022 Dec 1;220:109239. doi: 10.1016/j.neuropharm.2022.109239. Epub 2022 Sep 17.
10
Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions.人源多巴胺转运体酪氨酸 470 的突变对于 HIV-1 Tat 诱导的多巴胺转运抑制和转运体构象转变至关重要。
J Neuroimmune Pharmacol. 2013 Sep;8(4):975-87. doi: 10.1007/s11481-013-9464-6. Epub 2013 May 5.
引用本文的文献
1
Synthesis and evaluation of novel substituted N-(2-phenylbutyl)-5,6,7,8-tetrahydro-quinazolin-4-amines as allosteric modulators of HIV-DAT-tat interaction.新型取代的N-(2-苯基丁基)-5,6,7,8-四氢喹唑啉-4-胺作为HIV-DAT-反式激活转录蛋白相互作用变构调节剂的合成与评价
Bioorg Med Chem Lett. 2025 Dec 1;128:130345. doi: 10.1016/j.bmcl.2025.130345. Epub 2025 Jul 23.
2
Overview of the structure and function of the dopamine transporter and its protein interactions.多巴胺转运体的结构与功能及其蛋白质相互作用概述。
Front Physiol. 2023 Mar 3;14:1150355. doi: 10.3389/fphys.2023.1150355. eCollection 2023.
3
iTat transgenic mice exhibit hyper-locomotion in the behavioral pattern monitor after chronic exposure to methamphetamine but are unaffected by Tat expression.iTat 转基因小鼠在慢性接触甲基苯丙胺后在行为模式监测器中表现出过度活跃，但不受 Tat 表达的影响。
Pharmacol Biochem Behav. 2023 Jan;222:173499. doi: 10.1016/j.pbb.2022.173499. Epub 2022 Dec 1.
4
Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice.新型别构调节剂 Southern Research Institute-32743 逆转诱导型转录激活子转基因小鼠尾壳核中 HIV-1 转录激活因子诱导的多巴胺释放增加。
J Pharmacol Exp Ther. 2023 Feb;384(2):306-314. doi: 10.1124/jpet.122.001291. Epub 2022 Dec 1.
5
Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function.人去甲肾上腺素转运蛋白第 467 位酪氨酸突变可减弱 HIV-1 Tat 诱导的多巴胺转运抑制，同时保留生理功能。
PLoS One. 2022 Sep 28;17(9):e0275182. doi: 10.1371/journal.pone.0275182. eCollection 2022.
6
Substance abuse and neurotransmission.物质滥用与神经递质。
Adv Pharmacol. 2022;93:403-441. doi: 10.1016/bs.apha.2021.10.007. Epub 2022 Jan 17.
7
Crossroads of Drug Abuse and HIV Infection: Neurotoxicity and CNS Reservoir.药物滥用与艾滋病毒感染的交叉点：神经毒性与中枢神经系统储存库
Vaccines (Basel). 2022 Jan 27;10(2):202. doi: 10.3390/vaccines10020202.
8
Monoacylglycerol Lipase Inhibitor MJN110 Reduces Neuronal Hyperexcitability, Restores Dendritic Arborization Complexity, and Regulates Reward-Related Behavior in Presence of HIV-1 Tat.单酰甘油脂肪酶抑制剂MJN110可降低神经元的过度兴奋性，恢复树突分支复杂性，并在HIV-1 Tat存在的情况下调节与奖赏相关的行为。
Front Neurol. 2021 Aug 16;12:651272. doi: 10.3389/fneur.2021.651272. eCollection 2021.
9
Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport.人源多巴胺转运体酪氨酸 88、天冬氨酸 206 和组氨酸 547 的突变影响多巴胺的基础转运和 HIV-1 Tat 抑制的多巴胺转运。
J Neuroimmune Pharmacol. 2021 Dec;16(4):854-869. doi: 10.1007/s11481-021-09984-5. Epub 2021 Feb 3.
10
[H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription Protein.在表达 HIV-1 转录激活蛋白的转基因小鼠的前额叶皮层中，多巴胺和去甲肾上腺素转运体的多巴胺摄取减少。
J Pharmacol Exp Ther. 2020 Aug;374(2):241-251. doi: 10.1124/jpet.120.266023. Epub 2020 May 27.
本文引用的文献
1
Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats.多巴胺摄取抑制剂而非多巴胺释放剂在青少年大鼠中引起的运动行为和细胞外多巴胺增加幅度大于成年雄性大鼠。
J Pharmacol Exp Ther. 2010 Oct;335(1):124-32. doi: 10.1124/jpet.110.167320. Epub 2010 Jul 6.
2
Microarray analysis of cutaneous squamous cell carcinomas reveals enhanced expression of epidermal differentiation complex genes.皮肤鳞状细胞癌的微阵列分析显示表皮分化复合物基因表达增强。
Mol Carcinog. 2010 Jul;49(7):619-29. doi: 10.1002/mc.20636.
3
Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction.人类免疫缺陷病毒相关神经认知障碍：与药物成瘾相关的发病机制。
Ann N Y Acad Sci. 2010 Feb;1187:122-8. doi: 10.1111/j.1749-6632.2009.05277.x.
4
HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.HIV-1反式激活蛋白诱导[3H]多巴胺摄取快速且可逆地减少：大鼠纹状体突触体中[3H]多巴胺摄取与[3H]2β-甲氧羰基-3β-(4-氟苯基)托烷（WIN 35,428）结合的解离
J Pharmacol Exp Ther. 2009 Jun;329(3):1071-83. doi: 10.1124/jpet.108.150144. Epub 2009 Mar 26.
5
Intra-accumbal Tat1-72 alters acute and sensitized responses to cocaine.伏隔核内的Tat1-72改变对可卡因的急性和敏感反应。
Pharmacol Biochem Behav. 2008 Oct;90(4):723-9. doi: 10.1016/j.pbb.2008.05.020.
6
Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse.脑内多巴胺转运体减少与有无可卡因滥用的HIV患者的认知缺陷有关。
Neuroimage. 2008 Aug 15;42(2):869-78. doi: 10.1016/j.neuroimage.2008.05.011. Epub 2008 May 20.
7
Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine release.生物胺转运体的研究。12. 苯丙胺诱导的多巴胺释放新型部分抑制剂的鉴定。
J Pharmacol Exp Ther. 2008 Jul;326(1):286-95. doi: 10.1124/jpet.108.139675. Epub 2008 Apr 25.
8
Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.人类免疫缺陷病毒（HIV）、精神刺激类滥用药物的神经毒性特征及其对大脑的协同作用：神经艾滋病中多巴胺系统易损性的现状
Neurosci Biobehav Rev. 2008 Jul;32(5):883-909. doi: 10.1016/j.neubiorev.2008.01.004. Epub 2008 Mar 18.
9
Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function.雌激素可减轻由gp120和tat1-72诱导的氧化应激，并防止多巴胺转运体功能丧失。
Synapse. 2006 Jan;59(1):51-60. doi: 10.1002/syn.20214.
10
Decreased brain dopaminergic transporters in HIV-associated dementia patients.人类免疫缺陷病毒相关性痴呆患者脑内多巴胺能转运体减少。
Brain. 2004 Nov;127(Pt 11):2452-8. doi: 10.1093/brain/awh269. Epub 2004 Aug 19.
Zotero 插件